Jin-shui Huan-xian Formula for Retarding the Decline of Pulmonary Function in IPF

NANot yet recruitingINTERVENTIONAL
Enrollment

384

Participants

Timeline

Start Date

August 1, 2025

Primary Completion Date

June 30, 2028

Study Completion Date

November 30, 2028

Conditions
Idiopathic Pulmonary Fibrosis(IPF)
Interventions
DRUG

Jin-shui Huan-xian granule

"Jin-shui Huan-xian Granules: on the basis of treatment guided by Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults: An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline , the experimental group was given Jin-shui Huan-xian Granules for treatment. The granules were taken orally, 1 dose per day, twice a day, and the continuous administration lasted for 52 weeks."

DRUG

Jin-shui Huan-xian granule placebo

"Jin-shui Huan-xian granule placebo: on the basis of treatment guided by Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults: An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline , the experimental group was given Jin-shui Huan-xian Granules placebo for treatment. The granules were taken orally, 1 dose per day, twice a day, and the continuous administration lasted for 52 weeks.The Jin-shui Huan-xian granules and their placebo are identical in appearance, weight, color and smell."

Trial Locations (1)

450056

the First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou

All Listed Sponsors
lead

Henan University of Traditional Chinese Medicine

OTHER